Pharma Industry News

ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has priced an underwritten public offering of 6,800,000 shares of its common stock at a price to the public of $3.30 per share.

Adamas Pharmaceuticals, Inc., a privately held company, announced that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for influenza to include centers in the United States, Canada and Europe.

FDA Approves Intravenous Formulation Of Pfizer's Revatio (Sildenafil) For Treatment Of Pulmonary Arterial Hypertension

Reuters Key Development - 35 minutes ago

Administration - FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension

Pfizer Executive:In Talks To Expand Licensing Pact With Aurobindo

Wall Street Journal - 1 hour ago
HYDERABAD (Dow Jones)--Pfizer Inc. (PFE) is looking to expand its licensing pact with Aurobindo Pharma Ltd. (524804.BY) to add more products and markets, a senior company executive said Friday ...

ARMONK, N.Y., Nov. 20 /PRNewswire-FirstCall/ -- IBM (NYSE: IBM) announced today that Impax Laboratories, Inc. (Nasdaq: IPXL), a technology-based specialty pharmaceutical company, is using IBM business analytics technology to gain stronger insights into their business and better predict risks and market opportunities.

HOUSTON, Nov. 20 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the 21st Annual Piper Jaffray Health Care Conference in New York on Wednesday, December 2, 2009 at 12:00 PM EST.

MADISON, N.J., Nov.

NATICK, Mass. and LONDON, Nov. 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S.

WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc.